Total Positions
100
Quarter
2025 Q4
Top Holding
CLMT (20.4%)
Top 10 Concentration
70.7%
Turnover Rate
23.4%
Sector HHI
0.18
Items per page:
1-25 of 100
| Stock | History | Sector / Type | Port % | Prev % | Rank / Prev | Conviction | Change | % Change | Influence | Shares | Mkt Value | Avg Cost | Price Held | 1st Owned | Source | Source Date | Date Reported |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
CLMT
Calumet, Inc.
|
Basic Materials | 20.38% | 20.79% |
#1
Prev: #1
|
8.2 | -610,262 | -21.6% |
P
S
|
2,214,969 | $44,011,434 | 2021 Q4 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
APO
Apollo Global M...
|
Financial Services | 15.08% | 12.09% |
#2
Prev: #2
|
6.0 | no change | no change |
P
S
|
225,000 | $32,571,000 | 2021 Q4 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
GOOG
Alphabet Inc-Cl...
|
Communication Services | 13.28% | 11.02% |
#3
Prev: #3
|
5.4 | -20,800 | -18.5% |
P
S
|
91,420 | $28,687,596 | 2021 Q4 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
SNDX
Syndax Pharmace...
|
Healthcare | 4.04% | 2.66% |
#4
3
Prev: #7
|
1.6 | -13,000 | -3.0% |
P
S
|
415,000 | $8,719,150 | 2024 Q1 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
XERS
Xeris Biopharma...
|
Healthcare | 3.53% | 3.33% |
#5
1
Prev: #6
|
1.4 | -45,000 | -4.4% |
P
S
|
970,000 | $7,614,500 | 2023 Q4 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
TVTX
Travere Therape...
|
Healthcare | 3.29% | 2.51% |
#6
3
Prev: #9
|
1.4 | -74,000 | -28.5% |
P
S
|
186,000 | $7,107,060 | 2023 Q3 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
BBIO
Bridgebio Pharm...
|
Healthcare | 3.01% | 1.78% |
#7
5
Prev: #12
|
1.2 | no change | no change |
P
S
|
85,000 | $6,501,650 | 2022 Q1 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
PTGX
Protagonist The...
|
Healthcare | 2.95% | 2.22% |
#8
3
Prev: #11
|
1.2 | -10,000 | -12.0% |
P
S
|
73,000 | $6,375,820 | 2023 Q3 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
JPM
JPMorgan Chase ...
|
Financial Services | 2.91% | 2.59% |
#9
1
Prev: #8
|
1.2 | -897 | -4.4% |
P
S
|
19,477 | $6,275,879 | 2021 Q4 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
JAAA
Janus Henderson...
|
ETF | 2.19% | 8.96% |
#10
6
Prev: #4
|
1.1 | -344,226 | -78.6% |
P
S
|
93,528 | $4,730,646 | 2023 Q3 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
VRDN
Viridian Therap...
|
Healthcare | 2.09% | 1.01% |
#11
7
Prev: #18
|
2.9 | 28,426 | 24.4% |
P
S
|
145,000 | $4,512,400 | 2024 Q4 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
CPRX
Catalyst Pharma...
|
Healthcare | 2.04% | 1.50% |
#12
4
Prev: #16
|
0.8 | no change | no change |
P
S
|
189,000 | $4,411,260 | 2023 Q4 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
COGT
Cogent Bioscien...
|
Healthcare | 1.68% | — |
#13
Prev: #—
|
2.7 | 102,000 | no change |
NEW
|
102,000 | $3,623,040 | 2025 Q1 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
RCUS
Arcus Bioscienc...
|
Healthcare | 1.34% | 0.52% |
#14
14
Prev: #28
|
2.6 | 26,041 | 27.4% |
P
S
|
121,241 | $2,889,173 | 2025 Q1 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
ALKS
Alkermes PLC
|
Healthcare | 1.23% | 0.23% |
#15
35
Prev: #50
|
2.8 | 75,700 | 392.2% |
P
S
|
95,000 | $2,658,100 | 2023 Q2 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
DCGO
DocGo, Inc.
|
Healthcare | 1.09% | 1.68% |
#16
3
Prev: #13
|
0.5 | -400,000 | -13.0% |
P
S
|
2,670,850 | $2,344,472 | 2021 Q4 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
CYBN
Cybin Inc
|
Healthcare | 1.08% | 0.33% |
#17
22
Prev: #39
|
2.7 | 144,940 | 103.3% |
P
S
|
285,182 | $2,332,789 | 2024 Q4 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
CYTK
Cytokinetics, I...
|
Healthcare | 1.00% | 0.66% |
#18
7
Prev: #25
|
2.4 | 4,000 | 13.3% |
P
S
|
34,000 | $2,160,360 | 2024 Q1 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
ATRC
AtriCure, Inc.
|
Healthcare | 0.94% | 0.68% |
#19
5
Prev: #24
|
2.4 | 3,400 | 7.1% |
P
S
|
51,400 | $2,033,384 | 2025 Q1 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
AB
AllianceBernste...
|
Financial Services | 0.86% | 0.74% |
#20
3
Prev: #23
|
0.3 | no change | no change |
P
S
|
48,000 | $1,847,040 | 2021 Q4 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
ACLX
Arcellx Inc
|
Healthcare | 0.78% | 0.85% |
#21
Prev: #21
|
0.3 | no change | no change |
P
S
|
25,700 | $1,675,640 | 2023 Q1 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
XBI
SPDR S&P Biotec...
|
ETF | 0.73% | 0.20% |
#22
30
Prev: #52
|
2.6 | 8,000 | 160.0% |
P
S
|
13,000 | $1,585,090 | 2021 Q4 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
TECX
Tectonic Therap...
|
Healthcare | 0.71% | 0.47% |
#23
10
Prev: #33
|
0.3 | no change | no change |
P
S
|
74,000 | $1,543,640 | 2025 Q1 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
WVE
Wave Life Scien...
|
Healthcare | 0.71% | 0.27% |
#24
20
Prev: #44
|
0.3 | no change | no change |
P
S
|
90,000 | $1,530,000 | 2025 Q1 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
JNJ
Johnson & Johns...
|
Healthcare | 0.66% | 0.52% |
#25
4
Prev: #29
|
0.3 | no change | no change |
P
S
|
6,922 | $1,432,508 | 2021 Q4 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
DAR
CALL
Darling Ingredi...
|
CALL Option | 0.00% | 3.73% |
Sold All 😨
(Was: #5) |
0.3 | -300,000 | -100.0% |
CLOSED
|
— | $— | 2025 Q3 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
AVDL
Avadel Pharmace...
|
Healthcare | 0.00% | 2.24% |
Sold All 😨
(Was: #10) |
0.3 | -363,000 | -100.0% |
CLOSED
|
— | $— | 2021 Q4 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
VRNA
Verona Pharma P...
|
Unknown | 0.00% | 1.65% |
Sold All 😨
(Was: #14) |
0.3 | -38,355 | -100.0% |
CLOSED
|
— | $— | 2023 Q4 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
CSX
CSX Corporation
|
Industrials | 0.00% | 1.00% |
Sold All 😨
(Was: #19) |
0.3 | -70,000 | -100.0% |
CLOSED
|
— | $— | 2022 Q4 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
LQDA
Liquidia Corpor...
|
Healthcare | 0.00% | 0.99% |
Sold All 😨
(Was: #20) |
0.3 | -107,783 | -100.0% |
CLOSED
|
— | $— | 2021 Q4 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
PRAX
Praxis Precisio...
|
Healthcare | 0.00% | 0.60% |
Sold All 😨
(Was: #27) |
0.3 | -28,000 | -100.0% |
CLOSED
|
— | $— | 2025 Q3 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
ABBV
AbbVie Inc.
|
Healthcare | 0.00% | 0.47% |
Sold All 😨
(Was: #32) |
0.3 | -5,037 | -100.0% |
CLOSED
|
— | $— | 2021 Q4 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
BCRX
BioCryst Pharma...
|
Healthcare | 0.00% | 0.10% |
Sold All 😨
(Was: #60) |
0.3 | -32,570 | -100.0% |
CLOSED
|
— | $— | 2024 Q2 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
LLY
Eli Lilly & Co.
|
Healthcare | 0.00% | 0.09% |
Sold All 😨
(Was: #63) |
0.3 | -300 | -100.0% |
CLOSED
|
— | $— | 2021 Q4 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
IWR
iShares Russell...
|
ETF | 0.00% | 0.04% |
Sold All 😨
(Was: #68) |
0.3 | -695 | -100.0% |
CLOSED
|
— | $— | 2025 Q3 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
TTE
Total Energies
|
Energy | 0.00% | 0.03% |
Sold All 😨
(Was: #73) |
0.3 | -1,200 | -100.0% |
CLOSED
|
— | $— | 2021 Q4 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
FSIC
FS KKR Capital ...
|
Unknown | 0.00% | 0.02% |
Sold All 😨
(Was: #76) |
0.3 | -2,875 | -100.0% |
CLOSED
|
— | $— | 2022 Q2 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
AETUF
Arc Resources L...
|
Energy | 0.00% | 0.01% |
Sold All 😨
(Was: #82) |
0.3 | -1,110 | -100.0% |
CLOSED
|
— | $— | 2025 Q1 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) |
Showing 1-25 of 100 holdings